Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Genomic Valley Biotech Financial Results

Genomic Valley Biotech approved FY26 audited results, reporting a total revenue of ₹0.27 Crore. The company also appointed Mr. Navjyoti Kumar Jha as Internal Auditor.

Key figures
Value₹0.27 Cr
Source

BSE filing, NSE: GVBL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Genomic Valley Biotech Ltd: key numbers

Share price
₹43.63
Market cap
₹13.33 Cr
Revenue (annual)
₹0.27 Cr
Net profit (annual)
₹0.03 Cr
P/E (TTM)
655.2×Sector 46.1×
Promoter holding
46.06%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Genomic Valley Biotech Ltd

All →

Other financial results announcements

All →